Determination of Drug-Kinase Residence Time with the Transcreener ADP<sup>2</sup> FP Assay

11 Nov 2014

This application note provides a protocol and experimental example for the use of the Transcreener® ADP2 FP Assay to determine the residence time of a drug (or drug candidate) during its interaction with a kinase.

Transcreener® ADP² Kinase Assays

BellBrook Labs

The Transcreener® ADP² Kinase Assay Kit universally detects ADP produced by any kinase or ATPase using a direct mix‑and‑read format, eliminating coupling steps. Available in FP, FI, and TR‑FRET formats with far‑red tracers to minimize interference, it's HTS-ready across 96‑, 384‑, and 1536‑well plates with robust Z' ≥ 0.7 performance.

(3)

Links

Tags

Determination of Drug-Kinase Residence Time with the Transcreener ADP<sup>2</sup> FP Assay